Industry Research Reports

Home > Reports > Medical Care > Automation in Biopharma - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Automation in Biopharma - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-12

Pages: 133 Pages

Report ld: 2625239

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Automation in Biopharma was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Automation in Biopharma, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Automation in Biopharma by region & country, by Type, and by Application.

The Automation in Biopharma market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automation in Biopharma.

Market Segmentation

Report Metric
Details
Report Title
Automation in Biopharma - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Automation in Biopharma Companies Covered
GE, PerkinElmer, Tecan Journal, Thermo Fisher Scientific, Bruker Corporation, Peak Analysis & Automation, Sartorius, Siemens, Rockwell, Zenith (Cognizant), RheoSense, Inc., Werum, Emerson, TetraScience, BioProcess International, Novasep
Global Automation in Biopharma Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Automation in Biopharma Market, Segment by Type
IoT

AI

Digital Twin

AR & VR

Predictive Analytics

Cloud Computing
Global Automation in Biopharma Market, Segment by Application
Large Pharmaceutical Factory

Small and Medium-sized Pharmaceutical Factory

Biopharmaceutical Laboratory

Other
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Automation in Biopharma manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Automation in Biopharma in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Automation in Biopharma in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Automation in Biopharma Product Introduction
    1.2 Global Automation in Biopharma Market Size Forecast
    1.3 Automation in Biopharma Market Trends & Drivers
        1.3.1 Automation in Biopharma Industry Trends
        1.3.2 Automation in Biopharma Market Drivers & Opportunity
        1.3.3 Automation in Biopharma Market Challenges
        1.3.4 Automation in Biopharma Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Automation in Biopharma Players Revenue Ranking (2023)
    2.2 Global Automation in Biopharma Revenue by Company (2019-2024)
    2.3 Key Companies Automation in Biopharma Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Automation in Biopharma Product Offered
    2.5 Key Companies Time to Begin Mass Production of Automation in Biopharma
    2.6 Automation in Biopharma Market Competitive Analysis
        2.6.1 Automation in Biopharma Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Automation in Biopharma Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Automation in Biopharma as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 IoT
        3.1.2 AI
        3.1.3 Digital Twin
        3.1.4 AR & VR
        3.1.5 Predictive Analytics
        3.1.6 Cloud Computing
    3.2 Global Automation in Biopharma Sales Value by Type
        3.2.1 Global Automation in Biopharma Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Automation in Biopharma Sales Value, by Type (2019-2030)
        3.2.3 Global Automation in Biopharma Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Large Pharmaceutical Factory
        4.1.2 Small and Medium-sized Pharmaceutical Factory
        4.1.3 Biopharmaceutical Laboratory
        4.1.4 Other
    4.2 Global Automation in Biopharma Sales Value by Application
        4.2.1 Global Automation in Biopharma Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Automation in Biopharma Sales Value, by Application (2019-2030)
        4.2.3 Global Automation in Biopharma Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Automation in Biopharma Sales Value by Region
        5.1.1 Global Automation in Biopharma Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Automation in Biopharma Sales Value by Region (2019-2024)
        5.1.3 Global Automation in Biopharma Sales Value by Region (2025-2030)
        5.1.4 Global Automation in Biopharma Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Automation in Biopharma Sales Value, 2019-2030
        5.2.2 North America Automation in Biopharma Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Automation in Biopharma Sales Value, 2019-2030
        5.3.2 Europe Automation in Biopharma Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Automation in Biopharma Sales Value, 2019-2030
        5.4.2 Asia Pacific Automation in Biopharma Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Automation in Biopharma Sales Value, 2019-2030
        5.5.2 South America Automation in Biopharma Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Automation in Biopharma Sales Value, 2019-2030
        5.6.2 Middle East & Africa Automation in Biopharma Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Automation in Biopharma Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Automation in Biopharma Sales Value
    6.3 United States
        6.3.1 United States Automation in Biopharma Sales Value, 2019-2030
        6.3.2 United States Automation in Biopharma Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Automation in Biopharma Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Automation in Biopharma Sales Value, 2019-2030
        6.4.2 Europe Automation in Biopharma Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Automation in Biopharma Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Automation in Biopharma Sales Value, 2019-2030
        6.5.2 China Automation in Biopharma Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Automation in Biopharma Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Automation in Biopharma Sales Value, 2019-2030
        6.6.2 Japan Automation in Biopharma Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Automation in Biopharma Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Automation in Biopharma Sales Value, 2019-2030
        6.7.2 South Korea Automation in Biopharma Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Automation in Biopharma Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Automation in Biopharma Sales Value, 2019-2030
        6.8.2 Southeast Asia Automation in Biopharma Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Automation in Biopharma Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Automation in Biopharma Sales Value, 2019-2030
        6.9.2 India Automation in Biopharma Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Automation in Biopharma Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 GE
        7.1.1 GE Profile
        7.1.2 GE Main Business
        7.1.3 GE Automation in Biopharma Products, Services and Solutions
        7.1.4 GE Automation in Biopharma Revenue (US$ Million) & (2019-2024)
        7.1.5 GE Recent Developments
    7.2 PerkinElmer
        7.2.1 PerkinElmer Profile
        7.2.2 PerkinElmer Main Business
        7.2.3 PerkinElmer Automation in Biopharma Products, Services and Solutions
        7.2.4 PerkinElmer Automation in Biopharma Revenue (US$ Million) & (2019-2024)
        7.2.5 PerkinElmer Recent Developments
    7.3 Tecan Journal
        7.3.1 Tecan Journal Profile
        7.3.2 Tecan Journal Main Business
        7.3.3 Tecan Journal Automation in Biopharma Products, Services and Solutions
        7.3.4 Tecan Journal Automation in Biopharma Revenue (US$ Million) & (2019-2024)
        7.3.5 Thermo Fisher Scientific Recent Developments
    7.4 Thermo Fisher Scientific
        7.4.1 Thermo Fisher Scientific Profile
        7.4.2 Thermo Fisher Scientific Main Business
        7.4.3 Thermo Fisher Scientific Automation in Biopharma Products, Services and Solutions
        7.4.4 Thermo Fisher Scientific Automation in Biopharma Revenue (US$ Million) & (2019-2024)
        7.4.5 Thermo Fisher Scientific Recent Developments
    7.5 Bruker Corporation
        7.5.1 Bruker Corporation Profile
        7.5.2 Bruker Corporation Main Business
        7.5.3 Bruker Corporation Automation in Biopharma Products, Services and Solutions
        7.5.4 Bruker Corporation Automation in Biopharma Revenue (US$ Million) & (2019-2024)
        7.5.5 Bruker Corporation Recent Developments
    7.6 Peak Analysis & Automation
        7.6.1 Peak Analysis & Automation Profile
        7.6.2 Peak Analysis & Automation Main Business
        7.6.3 Peak Analysis & Automation Automation in Biopharma Products, Services and Solutions
        7.6.4 Peak Analysis & Automation Automation in Biopharma Revenue (US$ Million) & (2019-2024)
        7.6.5 Peak Analysis & Automation Recent Developments
    7.7 Sartorius
        7.7.1 Sartorius Profile
        7.7.2 Sartorius Main Business
        7.7.3 Sartorius Automation in Biopharma Products, Services and Solutions
        7.7.4 Sartorius Automation in Biopharma Revenue (US$ Million) & (2019-2024)
        7.7.5 Sartorius Recent Developments
    7.8 Siemens
        7.8.1 Siemens Profile
        7.8.2 Siemens Main Business
        7.8.3 Siemens Automation in Biopharma Products, Services and Solutions
        7.8.4 Siemens Automation in Biopharma Revenue (US$ Million) & (2019-2024)
        7.8.5 Siemens Recent Developments
    7.9 Rockwell
        7.9.1 Rockwell Profile
        7.9.2 Rockwell Main Business
        7.9.3 Rockwell Automation in Biopharma Products, Services and Solutions
        7.9.4 Rockwell Automation in Biopharma Revenue (US$ Million) & (2019-2024)
        7.9.5 Rockwell Recent Developments
    7.10 Zenith (Cognizant)
        7.10.1 Zenith (Cognizant) Profile
        7.10.2 Zenith (Cognizant) Main Business
        7.10.3 Zenith (Cognizant) Automation in Biopharma Products, Services and Solutions
        7.10.4 Zenith (Cognizant) Automation in Biopharma Revenue (US$ Million) & (2019-2024)
        7.10.5 Zenith (Cognizant) Recent Developments
    7.11 RheoSense, Inc.
        7.11.1 RheoSense, Inc. Profile
        7.11.2 RheoSense, Inc. Main Business
        7.11.3 RheoSense, Inc. Automation in Biopharma Products, Services and Solutions
        7.11.4 RheoSense, Inc. Automation in Biopharma Revenue (US$ Million) & (2019-2024)
        7.11.5 RheoSense, Inc. Recent Developments
    7.12 Werum
        7.12.1 Werum Profile
        7.12.2 Werum Main Business
        7.12.3 Werum Automation in Biopharma Products, Services and Solutions
        7.12.4 Werum Automation in Biopharma Revenue (US$ Million) & (2019-2024)
        7.12.5 Werum Recent Developments
    7.13 Emerson
        7.13.1 Emerson Profile
        7.13.2 Emerson Main Business
        7.13.3 Emerson Automation in Biopharma Products, Services and Solutions
        7.13.4 Emerson Automation in Biopharma Revenue (US$ Million) & (2019-2024)
        7.13.5 Emerson Recent Developments
    7.14 TetraScience
        7.14.1 TetraScience Profile
        7.14.2 TetraScience Main Business
        7.14.3 TetraScience Automation in Biopharma Products, Services and Solutions
        7.14.4 TetraScience Automation in Biopharma Revenue (US$ Million) & (2019-2024)
        7.14.5 TetraScience Recent Developments
    7.15 BioProcess International
        7.15.1 BioProcess International Profile
        7.15.2 BioProcess International Main Business
        7.15.3 BioProcess International Automation in Biopharma Products, Services and Solutions
        7.15.4 BioProcess International Automation in Biopharma Revenue (US$ Million) & (2019-2024)
        7.15.5 BioProcess International Recent Developments
    7.16 Novasep
        7.16.1 Novasep Profile
        7.16.2 Novasep Main Business
        7.16.3 Novasep Automation in Biopharma Products, Services and Solutions
        7.16.4 Novasep Automation in Biopharma Revenue (US$ Million) & (2019-2024)
        7.16.5 Novasep Recent Developments

 8 Industry Chain Analysis
    8.1 Automation in Biopharma Industrial Chain
    8.2 Automation in Biopharma Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Automation in Biopharma Sales Model
        8.5.2 Sales Channel
        8.5.3 Automation in Biopharma Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Automation in Biopharma Market Trends
    Table 2. Automation in Biopharma Market Drivers & Opportunity
    Table 3. Automation in Biopharma Market Challenges
    Table 4. Automation in Biopharma Market Restraints
    Table 5. Global Automation in Biopharma Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Automation in Biopharma Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Automation in Biopharma Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Automation in Biopharma Product Type
    Table 9. Key Companies Time to Begin Mass Production of Automation in Biopharma
    Table 10. Global Automation in Biopharma Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Automation in Biopharma as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Automation in Biopharma Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Automation in Biopharma Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Automation in Biopharma Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Automation in Biopharma Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Automation in Biopharma Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Automation in Biopharma Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Automation in Biopharma Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Automation in Biopharma Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Automation in Biopharma Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Automation in Biopharma Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Automation in Biopharma Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Automation in Biopharma Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Automation in Biopharma Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Automation in Biopharma Sales Value by Region (2019-2024) & (%)
    Table 27. Global Automation in Biopharma Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Automation in Biopharma Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Automation in Biopharma Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Automation in Biopharma Sales Value, (2025-2030) & (US$ Million)
    Table 31. GE Basic Information List
    Table 32. GE Description and Business Overview
    Table 33. GE Automation in Biopharma Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Automation in Biopharma Business of GE (2019-2024)
    Table 35. GE Recent Developments
    Table 36. PerkinElmer Basic Information List
    Table 37. PerkinElmer Description and Business Overview
    Table 38. PerkinElmer Automation in Biopharma Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Automation in Biopharma Business of PerkinElmer (2019-2024)
    Table 40. PerkinElmer Recent Developments
    Table 41. Tecan Journal Basic Information List
    Table 42. Tecan Journal Description and Business Overview
    Table 43. Tecan Journal Automation in Biopharma Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Automation in Biopharma Business of Tecan Journal (2019-2024)
    Table 45. Tecan Journal Recent Developments
    Table 46. Thermo Fisher Scientific Basic Information List
    Table 47. Thermo Fisher Scientific Description and Business Overview
    Table 48. Thermo Fisher Scientific Automation in Biopharma Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Automation in Biopharma Business of Thermo Fisher Scientific (2019-2024)
    Table 50. Thermo Fisher Scientific Recent Developments
    Table 51. Bruker Corporation Basic Information List
    Table 52. Bruker Corporation Description and Business Overview
    Table 53. Bruker Corporation Automation in Biopharma Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Automation in Biopharma Business of Bruker Corporation (2019-2024)
    Table 55. Bruker Corporation Recent Developments
    Table 56. Peak Analysis & Automation Basic Information List
    Table 57. Peak Analysis & Automation Description and Business Overview
    Table 58. Peak Analysis & Automation Automation in Biopharma Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Automation in Biopharma Business of Peak Analysis & Automation (2019-2024)
    Table 60. Peak Analysis & Automation Recent Developments
    Table 61. Sartorius Basic Information List
    Table 62. Sartorius Description and Business Overview
    Table 63. Sartorius Automation in Biopharma Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Automation in Biopharma Business of Sartorius (2019-2024)
    Table 65. Sartorius Recent Developments
    Table 66. Siemens Basic Information List
    Table 67. Siemens Description and Business Overview
    Table 68. Siemens Automation in Biopharma Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Automation in Biopharma Business of Siemens (2019-2024)
    Table 70. Siemens Recent Developments
    Table 71. Rockwell Basic Information List
    Table 72. Rockwell Description and Business Overview
    Table 73. Rockwell Automation in Biopharma Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Automation in Biopharma Business of Rockwell (2019-2024)
    Table 75. Rockwell Recent Developments
    Table 76. Zenith (Cognizant) Basic Information List
    Table 77. Zenith (Cognizant) Description and Business Overview
    Table 78. Zenith (Cognizant) Automation in Biopharma Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Automation in Biopharma Business of Zenith (Cognizant) (2019-2024)
    Table 80. Zenith (Cognizant) Recent Developments
    Table 81. RheoSense, Inc. Basic Information List
    Table 82. RheoSense, Inc. Description and Business Overview
    Table 83. RheoSense, Inc. Automation in Biopharma Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Automation in Biopharma Business of RheoSense, Inc. (2019-2024)
    Table 85. RheoSense, Inc. Recent Developments
    Table 86. Werum Basic Information List
    Table 87. Werum Description and Business Overview
    Table 88. Werum Automation in Biopharma Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Automation in Biopharma Business of Werum (2019-2024)
    Table 90. Werum Recent Developments
    Table 91. Emerson Basic Information List
    Table 92. Emerson Description and Business Overview
    Table 93. Emerson Automation in Biopharma Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Automation in Biopharma Business of Emerson (2019-2024)
    Table 95. Emerson Recent Developments
    Table 96. TetraScience Basic Information List
    Table 97. TetraScience Description and Business Overview
    Table 98. TetraScience Automation in Biopharma Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Automation in Biopharma Business of TetraScience (2019-2024)
    Table 100. TetraScience Recent Developments
    Table 101. BioProcess International Basic Information List
    Table 102. BioProcess International Description and Business Overview
    Table 103. BioProcess International Automation in Biopharma Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Automation in Biopharma Business of BioProcess International (2019-2024)
    Table 105. BioProcess International Recent Developments
    Table 106. Novasep Basic Information List
    Table 107. Novasep Description and Business Overview
    Table 108. Novasep Automation in Biopharma Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Automation in Biopharma Business of Novasep (2019-2024)
    Table 110. Novasep Recent Developments
    Table 111. Key Raw Materials Lists
    Table 112. Raw Materials Key Suppliers Lists
    Table 113. Automation in Biopharma Downstream Customers
    Table 114. Automation in Biopharma Distributors List
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
    Table 118. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Automation in Biopharma Product Picture
    Figure 2. Global Automation in Biopharma Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Automation in Biopharma Sales Value (2019-2030) & (US$ Million)
    Figure 4. Automation in Biopharma Report Years Considered
    Figure 5. Global Automation in Biopharma Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Automation in Biopharma Revenue in 2023
    Figure 7. Automation in Biopharma Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. IoT Picture
    Figure 9. AI Picture
    Figure 10. Digital Twin Picture
    Figure 11. AR & VR Picture
    Figure 12. Predictive Analytics Picture
    Figure 13. Cloud Computing Picture
    Figure 14. Global Automation in Biopharma Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Automation in Biopharma Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Product Picture of Large Pharmaceutical Factory
    Figure 17. Product Picture of Small and Medium-sized Pharmaceutical Factory
    Figure 18. Product Picture of Biopharmaceutical Laboratory
    Figure 19. Product Picture of Other
    Figure 20. Global Automation in Biopharma Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Automation in Biopharma Sales Value Market Share by Application, 2023 & 2030
    Figure 22. North America Automation in Biopharma Sales Value (2019-2030) & (US$ Million)
    Figure 23. North America Automation in Biopharma Sales Value by Country (%), 2023 VS 2030
    Figure 24. Europe Automation in Biopharma Sales Value (2019-2030) & (US$ Million)
    Figure 25. Europe Automation in Biopharma Sales Value by Country (%), 2023 VS 2030
    Figure 26. Asia Pacific Automation in Biopharma Sales Value (2019-2030) & (US$ Million)
    Figure 27. Asia Pacific Automation in Biopharma Sales Value by Country (%), 2023 VS 2030
    Figure 28. South America Automation in Biopharma Sales Value (2019-2030) & (US$ Million)
    Figure 29. South America Automation in Biopharma Sales Value by Country (%), 2023 VS 2030
    Figure 30. Middle East & Africa Automation in Biopharma Sales Value (2019-2030) & (US$ Million)
    Figure 31. Middle East & Africa Automation in Biopharma Sales Value by Country (%), 2023 VS 2030
    Figure 32. Key Countries/Regions Automation in Biopharma Sales Value (%), (2019-2030)
    Figure 33. United States Automation in Biopharma Sales Value, (2019-2030) & (US$ Million)
    Figure 34. United States Automation in Biopharma Sales Value by Type (%), 2023 VS 2030
    Figure 35. United States Automation in Biopharma Sales Value by Application (%), 2023 VS 2030
    Figure 36. Europe Automation in Biopharma Sales Value, (2019-2030) & (US$ Million)
    Figure 37. Europe Automation in Biopharma Sales Value by Type (%), 2023 VS 2030
    Figure 38. Europe Automation in Biopharma Sales Value by Application (%), 2023 VS 2030
    Figure 39. China Automation in Biopharma Sales Value, (2019-2030) & (US$ Million)
    Figure 40. China Automation in Biopharma Sales Value by Type (%), 2023 VS 2030
    Figure 41. China Automation in Biopharma Sales Value by Application (%), 2023 VS 2030
    Figure 42. Japan Automation in Biopharma Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Japan Automation in Biopharma Sales Value by Type (%), 2023 VS 2030
    Figure 44. Japan Automation in Biopharma Sales Value by Application (%), 2023 VS 2030
    Figure 45. South Korea Automation in Biopharma Sales Value, (2019-2030) & (US$ Million)
    Figure 46. South Korea Automation in Biopharma Sales Value by Type (%), 2023 VS 2030
    Figure 47. South Korea Automation in Biopharma Sales Value by Application (%), 2023 VS 2030
    Figure 48. Southeast Asia Automation in Biopharma Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Southeast Asia Automation in Biopharma Sales Value by Type (%), 2023 VS 2030
    Figure 50. Southeast Asia Automation in Biopharma Sales Value by Application (%), 2023 VS 2030
    Figure 51. India Automation in Biopharma Sales Value, (2019-2030) & (US$ Million)
    Figure 52. India Automation in Biopharma Sales Value by Type (%), 2023 VS 2030
    Figure 53. India Automation in Biopharma Sales Value by Application (%), 2023 VS 2030
    Figure 54. Automation in Biopharma Industrial Chain
    Figure 55. Automation in Biopharma Manufacturing Cost Structure
    Figure 56. Channels of Distribution (Direct Sales, and Distribution)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation

Description

The global market for Automation in Biopharma was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Automation in Biopharma, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Automation in Biopharma by region & country, by Type, and by Application.

The Automation in Biopharma market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automation in Biopharma.

Market Segmentation